(Total Views: 454)
Posted On: 11/19/2023 3:38:06 PM
Post# of 144908
It's possible that study was three-armed, Keytruda, Keytruda+leronlimab and placebo. At some point prior to a phase1a trial the FDA would want to see a four phase study with one of the phases being leronlimab alone to sort out any safety issues. The best way to start that off is with the initial pre-clinical study.
(9)
(0)